US Stock MarketDetailed Quotes

MACK Merrimack Pharmaceuticals

Watchlist

15.130
0.0000.00%

Trading May 17 16:00 ET

223.75MMarket Cap1.09P/E (TTM)

Merrimack Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

1,158.23%244.11M

-2.90%18.88M

44.40%18.9M

42.03%18.97M

35.73%19.4M

36.87%19.44M

-10.08%13.09M

-10.42%13.36M

-Cash and cash equivalents

1,106.95%234.16M

-69.19%5.99M

-53.53%6.08M

-24.14%10.13M

35.73%19.4M

36.87%19.44M

-10.08%13.09M

-10.42%13.36M

-Short-term investments

--9.95M

--12.89M

--12.82M

--8.84M

----

--0

----

Other current assets

-7.93%209K

-20.57%309K

-27.37%390K

-31.30%474K

-29.06%227K

-18.96%389K

-15.57%537K

-14.29%690K

Total current assets

1,144.75%244.32M

-3.25%19.18M

41.58%19.29M

38.43%19.44M

34.31%19.63M

35.04%19.83M

-10.31%13.63M

-10.62%14.05M

Non current assets

Other non current assets

-57.14%3K

-50.00%4K

-44.44%5K

-40.00%6K

-72.00%7K

-87.88%8K

-91.67%9K

-93.29%10K

Total non current assets

-57.14%3K

-50.00%4K

-44.44%5K

-40.00%6K

-72.00%7K

-87.88%8K

-91.67%9K

-93.29%10K

Total assets

1,144.32%244.32M

-3.27%19.19M

41.52%19.3M

38.37%19.45M

34.13%19.64M

34.49%19.84M

-10.88%13.64M

-11.40%14.06M

Liabilities

Current liabilities

Payables

24,926.97%22.27M

-60.64%74K

65.67%111K

-4.76%80K

-49.72%89K

56.67%188K

-35.58%67K

-51.45%84K

-accounts payable

88.76%168K

-60.64%74K

65.67%111K

-4.76%80K

-49.72%89K

56.67%188K

-35.58%67K

-51.45%84K

-Total tax payable

--22.11M

----

Current accrued expenses

13.11%207K

-16.19%176K

0.53%191K

-15.66%140K

-6.63%183K

-16.33%210K

-20.17%190K

-35.66%166K

Other current liabilities

0.00%191K

-43.99%191K

Current liabilities

4,796.76%22.67M

-25.13%441K

10.04%493K

-6.80%411K

-17.91%463K

4.80%589K

-34.41%448K

-42.88%441K

Non current liabilities

Total non current liabilities

--0

Total liabilities

4,796.76%22.67M

-25.13%441K

10.04%493K

-6.80%411K

-17.91%463K

4.80%589K

-34.41%448K

-42.88%441K

Shareholders'equity

Share capital

0.15%1.35M

0.07%1.34M

0.67%1.34M

0.60%1.34M

0.00%1.33M

-common stock

0.15%1.35M

0.07%1.34M

0.67%1.34M

0.60%1.34M

0.00%1.33M

-Preferred stock

--0

Retained earnings

36.59%-347.45M

-0.22%-548.82M

-0.26%-548.58M

-0.29%-548.3M

-0.31%-547.91M

-0.28%-547.64M

-0.28%-547.14M

-0.30%-546.7M

Paid-in capital

0.36%567.75M

0.12%566.22M

1.26%566.04M

1.25%565.99M

1.21%565.74M

1.18%565.54M

0.02%559M

0.02%558.98M

Total stockholders'equity

1,056.11%221.65M

-2.60%18.75M

42.59%18.81M

39.83%19.04M

36.21%19.17M

35.67%19.25M

-9.78%13.19M

-9.79%13.61M

Total equity

1,056.11%221.65M

-2.60%18.75M

42.59%18.81M

39.83%19.04M

36.21%19.17M

35.67%19.25M

-9.78%13.19M

-9.79%13.61M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	1,158.23%244.11M	-2.90%18.88M	-2.90%18.88M	44.40%18.9M	42.03%18.97M	35.73%19.4M	36.87%19.44M	36.87%19.44M	-10.08%13.09M	-10.42%13.36M
-Cash and cash equivalents	1,106.95%234.16M	-69.19%5.99M	-69.19%5.99M	-53.53%6.08M	-24.14%10.13M	35.73%19.4M	36.87%19.44M	36.87%19.44M	-10.08%13.09M	-10.42%13.36M
-Short-term investments	--9.95M	--12.89M	--12.89M	--12.82M	--8.84M	----	--0	--0	----	----
Other current assets	-7.93%209K	-20.57%309K	-20.57%309K	-27.37%390K	-31.30%474K	-29.06%227K	-18.96%389K	-18.96%389K	-15.57%537K	-14.29%690K
Total current assets	1,144.75%244.32M	-3.25%19.18M	-3.25%19.18M	41.58%19.29M	38.43%19.44M	34.31%19.63M	35.04%19.83M	35.04%19.83M	-10.31%13.63M	-10.62%14.05M
Non current assets
Other non current assets	-57.14%3K	-50.00%4K	-50.00%4K	-44.44%5K	-40.00%6K	-72.00%7K	-87.88%8K	-87.88%8K	-91.67%9K	-93.29%10K
Total non current assets	-57.14%3K	-50.00%4K	-50.00%4K	-44.44%5K	-40.00%6K	-72.00%7K	-87.88%8K	-87.88%8K	-91.67%9K	-93.29%10K
Total assets	1,144.32%244.32M	-3.27%19.19M	-3.27%19.19M	41.52%19.3M	38.37%19.45M	34.13%19.64M	34.49%19.84M	34.49%19.84M	-10.88%13.64M	-11.40%14.06M
Liabilities
Current liabilities
Payables	24,926.97%22.27M	-60.64%74K	-60.64%74K	65.67%111K	-4.76%80K	-49.72%89K	56.67%188K	56.67%188K	-35.58%67K	-51.45%84K
-accounts payable	88.76%168K	-60.64%74K	-60.64%74K	65.67%111K	-4.76%80K	-49.72%89K	56.67%188K	56.67%188K	-35.58%67K	-51.45%84K
-Total tax payable	--22.11M	----	----	----	----	----	----	----	----	----
Current accrued expenses	13.11%207K	-16.19%176K	-16.19%176K	0.53%191K	-15.66%140K	-6.63%183K	-16.33%210K	-16.33%210K	-20.17%190K	-35.66%166K
Other current liabilities	0.00%191K	0.00%191K	0.00%191K	0.00%191K	0.00%191K	0.00%191K	0.00%191K	0.00%191K	-43.99%191K	-43.99%191K
Current liabilities	4,796.76%22.67M	-25.13%441K	-25.13%441K	10.04%493K	-6.80%411K	-17.91%463K	4.80%589K	4.80%589K	-34.41%448K	-42.88%441K
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	4,796.76%22.67M	-25.13%441K	-25.13%441K	10.04%493K	-6.80%411K	-17.91%463K	4.80%589K	4.80%589K	-34.41%448K	-42.88%441K
Shareholders'equity
Share capital	0.15%1.35M	0.07%1.34M	0.07%1.34M	0.67%1.34M	0.67%1.34M	0.67%1.34M	0.60%1.34M	0.60%1.34M	0.00%1.33M	0.00%1.33M
-common stock	0.15%1.35M	0.07%1.34M	0.07%1.34M	0.67%1.34M	0.67%1.34M	0.67%1.34M	0.60%1.34M	0.60%1.34M	0.00%1.33M	0.00%1.33M
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	36.59%-347.45M	-0.22%-548.82M	-0.22%-548.82M	-0.26%-548.58M	-0.29%-548.3M	-0.31%-547.91M	-0.28%-547.64M	-0.28%-547.64M	-0.28%-547.14M	-0.30%-546.7M
Paid-in capital	0.36%567.75M	0.12%566.22M	0.12%566.22M	1.26%566.04M	1.25%565.99M	1.21%565.74M	1.18%565.54M	1.18%565.54M	0.02%559M	0.02%558.98M
Total stockholders'equity	1,056.11%221.65M	-2.60%18.75M	-2.60%18.75M	42.59%18.81M	39.83%19.04M	36.21%19.17M	35.67%19.25M	35.67%19.25M	-9.78%13.19M	-9.79%13.61M
Total equity	1,056.11%221.65M	-2.60%18.75M	-2.60%18.75M	42.59%18.81M	39.83%19.04M	36.21%19.17M	35.67%19.25M	35.67%19.25M	-9.78%13.19M	-9.79%13.61M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data